학술논문
PD-026 - Rechallenge with cetuximab + irinotecan in 3rd-line in RAS and BRAF wild-type metastatic colorectal cancer (mCRC) patients with acquired resistance to 1st-line cetuximab+irinotecan: The phase II CRICKET study by GONO.
Document Type
Abstract
Author
Rossini, Daniele; Santini, Daniele; Cremolini, Chiara; Salvatore, Lisa; Lonardi, Sara; Dell' Aquila, Emanuela; Aprile, Giuseppe; Loupakis, Fotios; Vincenzi, Bruno; Battaglin, Francesca; Buoro, Vanessa; Tamburini, Emiliano; Basile, Deborah; Corsi, Domenico; Fioroni, Iacopo; Masi, Gianluca; Antoniotti, Carlotta; Borelli, Beatrice; Del Re, Marzia; Tonini, Giuseppe; Falcone, Alfredo
Source
In Annals of Oncology June 2017 28 Supplement 3:iii10-iii10
Subject
Language
ISSN
0923-7534